CMAJ • February 27, 2007; 176 (5). doi:10.1503/cmaj.061250.
© 2007 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v176,p1613)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schneeweiss, S.
Right arrow Articles by Wang, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneeweiss, S.
Right arrow Articles by Wang, P. S.
Related Collections
Right arrow Drugs: psychiatry
Right arrow Adverse drug reactions
Right arrow Psychogeriatrics
Right arrowRelated Articles

Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients

Sebastian Schneeweiss, Soko Setoguchi, Alan Brookhart, Colin Dormuth and Philip S. Wang

From the Division of Pharmacoepidemiology and Pharmacoeconomics (Schneeweiss, Setoguchi, Wang, Brookhart), Department of Medicine, and the Department of Psychiatry (Wang), Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.; the Therapeutics Initiative (Dormuth), Department of Anesthesia, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC; and the Division of Services and Intervention Research (Wang), National Institute of Mental Health, Bethesda, Md.


Figure 116
View larger version (31K):
[in this window]
[in a new window]

  		Fig. 1: Utilization trends of conventional and atypical antipsychotic medications (APMs) among 37 241 elderly people in British Columbia from January 1996 to December 2004.

 

View this table:
[in this window]
[in a new window]

  		Table 1.

 

View this table:
[in this window]
[in a new window]

  		Table 2.

 

Figure 216
View larger version (25K):
[in this window]
[in a new window]

  		Fig. 2: Yearly adjusted mortality ratios comparing the risk of death between the conventional and atypical antipsychotic drug groups, from 1997 to 2004. Error bars represent 95% confidence intervals.

 

View this table:
[in this window]
[in a new window]

  		Table 3.